147 related articles for article (PubMed ID: 38072401)
21. Nationwide Trends in the Incidence and Survival of Eyelid Skin Cancers in Korea.
Jung SK; Lim J; Yang SW; Jee D; Won YJ
Ophthalmic Epidemiol; 2020 Dec; 27(6):438-448. PubMed ID: 32486892
[TBL] [Abstract][Full Text] [Related]
22. Comparing the Characteristics and Outcomes of Male and Female Breast Cancer Patients in Korea: Korea Central Cancer Registry.
Lee EG; Jung SY; Lim MC; Lim J; Kang HS; Lee S; Han JH; Jo H; Won YJ; Lee ES
Cancer Res Treat; 2020 Jul; 52(3):739-746. PubMed ID: 32054149
[TBL] [Abstract][Full Text] [Related]
23. Patterns of care, predictors and outcomes of chemotherapy for ovarian carcinosarcoma: A National Cancer Database analysis.
Rauh-Hain JA; Gonzalez R; Bregar AJ; Clemmer J; Hernández-Blanquisett A; Clark RM; Schorge JO; Del Carmen MG
Gynecol Oncol; 2016 Jul; 142(1):38-43. PubMed ID: 27107722
[TBL] [Abstract][Full Text] [Related]
24. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014.
Jung KW; Won YJ; Oh CM; Kong HJ; Lee DH; Lee KH;
Cancer Res Treat; 2017 Apr; 49(2):292-305. PubMed ID: 28279062
[TBL] [Abstract][Full Text] [Related]
25. Incidence and survival rates of lymphoepithelioma-like gastric carcinoma: analysis of the Korea Central Cancer Registry Database.
Kim JW; Kim JH; Kim HM
Scand J Gastroenterol; 2021 Oct; 56(10):1182-1186. PubMed ID: 34338128
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of second primary breast cancer after ovarian cancer: a Korea central cancer registry retrospective study.
Lee EG; Lim J; Ha HI; Lim MC; Chang YJ; Won YJ; Jung SY
Front Oncol; 2023; 13():1208320. PubMed ID: 37781206
[TBL] [Abstract][Full Text] [Related]
27. Cancer Incidence and Survival among Adolescents and Young Adults in Korea: An Update for 2016.
Park M; Lim J; Lee JA; Park BK; Jung KW; Won YJ; Park HJ
Cancer Res Treat; 2021 Jan; 53(1):32-44. PubMed ID: 33017883
[TBL] [Abstract][Full Text] [Related]
28. Trends in Pediatric Thyroid Cancer Incidence, Treatment, and Clinical Course in Korea During 2004-2016: A Nationwide Population-Based Study.
Lee YA; Yun HR; Lee J; Moon H; Shin CH; Kim SG; Park YJ
Thyroid; 2021 Jun; 31(6):902-911. PubMed ID: 33107409
[No Abstract] [Full Text] [Related]
29. Incidence Patterns and Outcomes of Ewing Sarcoma in South Korea (1999-2017): A Retrospective Analysis Using Korea Central Cancer Registry Data.
Lee JA; Lim J; Park D; Jin HY; Park M; Park HJ; Park JW; Kim JH; Kang HG; Won YJ
Cancer Res Treat; 2022 Apr; 54(2):590-596. PubMed ID: 34281296
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological parameters and survival of invasive epithelial ovarian cancer by histotype and disease stage.
Lan A; Yang G
Future Oncol; 2019 Jun; 15(17):2029-2039. PubMed ID: 31140868
[No Abstract] [Full Text] [Related]
31. Ovarian cancer incidence and survival in Korea: 1993-2002.
Chung HH; Hwang SY; Jung KW; Won YJ; Shin HR; Kim JW; Lee HP;
Int J Gynecol Cancer; 2007; 17(3):595-600. PubMed ID: 17300678
[TBL] [Abstract][Full Text] [Related]
32. Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010.
Lim MC; Moon EK; Shin A; Jung KW; Won YJ; Seo SS; Kang S; Kim JW; Kim JY; Park SY
J Gynecol Oncol; 2013 Oct; 24(4):298-302. PubMed ID: 24167664
[TBL] [Abstract][Full Text] [Related]
33. Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.
Berton-Rigaud D; Devouassoux-Shisheboran M; Ledermann JA; Leitao MM; Powell MA; Poveda A; Beale P; Glasspool RM; Creutzberg CL; Harter P; Kim JW; Reed NS; Ray-Coquard I
Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S55-60. PubMed ID: 25341582
[TBL] [Abstract][Full Text] [Related]
34. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016.
Jung KW; Won YJ; Kong HJ; Lee ES
Cancer Res Treat; 2019 Apr; 51(2):417-430. PubMed ID: 30913865
[TBL] [Abstract][Full Text] [Related]
35. Incidence, treatment, and survival trends in older versus younger women with epithelial ovarian cancer from 2005 to 2018: A nationwide Danish study.
Ekmann-Gade AW; Høgdall CK; Seibæk L; Noer MC; Fagö-Olsen CL; Schnack TH
Gynecol Oncol; 2022 Jan; 164(1):120-128. PubMed ID: 34716025
[TBL] [Abstract][Full Text] [Related]
36. Trends in incidence and survival of patients with vulvar cancer in an Asian country: Analysis of the Korean Central Cancer Registry 1999-2018.
Shin DW; Bae J; Ha J; Lee WM; Jung KW
Gynecol Oncol; 2022 Feb; 164(2):386-392. PubMed ID: 34893346
[TBL] [Abstract][Full Text] [Related]
37. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
[TBL] [Abstract][Full Text] [Related]
38. Carcinosarcoma of the ovary compared to papillary serous ovarian carcinoma: a SEER analysis.
Rauh-Hain JA; Diver EJ; Clemmer JT; Bradford LS; Clark RM; Growdon WB; Goodman AK; Boruta DM; Schorge JO; del Carmen MG
Gynecol Oncol; 2013 Oct; 131(1):46-51. PubMed ID: 23906658
[TBL] [Abstract][Full Text] [Related]
39. Incidence and survival trends of uncommon corpus uteri malignancies in the Netherlands, 1989-2008.
Boll D; Verhoeven RH; van der Aa MA; Pauwels P; Karim-Kos HE; Coebergh JW; van Doorn HC
Int J Gynecol Cancer; 2012 May; 22(4):599-606. PubMed ID: 22398706
[TBL] [Abstract][Full Text] [Related]
40. Comparison of first-line chemotherapy regimens for ovarian carcinosarcoma: a single institution case series and review of the literature.
Brackmann M; Stasenko M; Uppal S; Erba J; Reynolds RK; McLean K
BMC Cancer; 2018 Feb; 18(1):172. PubMed ID: 29426293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
